Page last updated: 2024-10-20

uric acid and Erythroblastosis Fetalis

uric acid has been researched along with Erythroblastosis Fetalis in 2 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lindeman, JH2
Lentjes, EG1
Houdkamp, E2
van Zoeren-Grobben, D2
Schrijver, J2
Berger, HM2
Kanhai, HH1

Other Studies

2 other studies available for uric acid and Erythroblastosis Fetalis

ArticleYear
Effect of an exchange transfusion on plasma antioxidants in the newborn.
    Pediatrics, 1992, Volume: 90, Issue:2 Pt 1

    Topics: Adult; Antioxidants; Ascorbic Acid; Bilirubin; Blood Chemical Analysis; Blood Proteins; Ceruloplasmi

1992
Iron overload, free radical damage, and rhesus haemolytic disease.
    Lancet (London, England), 1990, Apr-21, Volume: 335, Issue:8695

    Topics: Antioxidants; Ascorbic Acid; Erythroblastosis, Fetal; Evaluation Studies as Topic; Female; Ferritins

1990